print-logo
Logo
  • Who we are Arrow Down
    • About us
    • Our purpose & values
    • Our team
    • News & events
  • What we do Arrow Down
    • Overview
    • Lifecycle Management
    • Health Policy
    • Market Access
    • Medical Affairs
    • Marketing
    • Commercial Models
    • Customer & Market Insights
  • Insights Arrow Down
    • Publications
    • Project cases
  • Careers Arrow Down
    • Why join us
    • Open positions
    • Career paths
    • FAQ
  • Contact
  • |
  • Search Icon
  • Search
Back to What we do
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

Medical Affairs

We support Medical Affairs in playing a pivotal, strategic role in helping pharmaceutical companies to regain trust and demonstrate the value of their products to a wide range of stakeholders.

The importance of Medical Affairs has increased dramatically over the past few years from a supporting, reactive function to a central, strategic, customer-facing one. This is because in today’s healthcare environment, Medical Affairs is uniquely placed to work closely with all stakeholders and to reignite trust.

The opportunity now exists for Medical Affairs to move beyond its traditional function towards:

  • Bridging the gap between R&D and Commercial by bringing patient-centric insights from a broader range of external medical decision-makers and influencers into clinical development
  • Establishing a continuous holistic evidence generation strategy beyond clinical evidence to achieve strong value propositions
  • Serving as trusted experts to an extended network of stakeholders by acting as facilitators of scientific information exchange
  • Acting as ambassadors of patient outcomes and the clinical point of view, by driving a patient-centric approach across all functions

You get access to a senior consulting team who has deep competency and experience in their respective areas.

– Global Top 10 Pharma, Director Medical Affairs

Contact our experts

Tanja Bosshard Becker

Tanja Bosshard Becker

Partner

mail_icon linkedin_icon
Wendy van der Lubbe

Wendy van der Lubbe

Director

mail_icon linkedin_icon
Aleksandar Ruzicic

Aleksandar Ruzicic

Partner

mail_icon linkedin_icon

Related project cases and publications

Global medical strategy for a new therapeutic class
Project Case

Global medical strategy for a new therapeutic class

Developing an affiliate toolkit for patient engagement excellence
Project Case

Developing an affiliate toolkit for patient engagement excellence

No Half Measures: How Medical Affairs can maximize and measure value
Publication

No Half Measures: How Medical Affairs can maximize and measure value

Navigating the maze of modern Medical Affairs stakeholder engagement
Publication

Navigating the maze of modern Medical Affairs stakeholder engagement

Patient evidence in HTA: Does it matter?
Publication

Patient evidence in HTA: Does it matter?

Embracing virtual patient care - What are the benefits of a virtual care approach for pharma?
Publication

Embracing virtual patient care - What are the benefits of a virtual care approach for pharma?

  • Back
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • More
Share this page
  • linkedin_icon
  • twitter_icon
  • mail_icon
  • print_icon

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK
arrow_up

How can we help?

Contact us

Our offices

Careers

Footer Logo
  • Who we are
  • What we do
  • Insights
  • Careers
  • Terms of use
  • Privacy policy
  • Imprint

2022 Executive Insight. All rights reserved.